Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
Abstract Background Infective endocarditis (IE) is a life-threatening disease whose prognosis is often difficult to predict based on clinical data. Biomarkers have been shown to favorably affect disease management in a number of cardiac disorders. Aims of this retrospective study were to assess the prognostic role of procalcitonin (PCT), pro-adrenomedullin (pro-ADM) and copeptin in IE and their relation with disease characteristics and the traditional biomarker C-reactive protein (CRP). Methods We studied 196 patients with definite IE. Clinical, laboratory and echocardiography parameters were analyzed, with a focus on co-morbidities. PCT, pro-ADM and copeptin were measured on stored plasma samples obtained on admission during the acute phase of the disease. Results Pro-ADM and copeptin were significantly higher in older patients and associated with prior chronic kidney disease. Pro-ADM was an independent predictor of hospital mortality (OR 3.29 [95%C.I. 1.04–11.5]; p = 0.042) whilst copeptin independently predicted 1-year mortality (OR 2.55 [95%C.I. 1.18–5.54]; p = 0.017). A high PCT value was strictly tied with S. aureus etiology (p = 0.001). CRP was the only biomarker associated with embolic events (p = 0.003). Conclusions Different biomarkers correlate with distinct IE outcomes. Pro-ADM and copeptin may signal a worse prognosis of IE on admission to the hospital and could be used to identify patients who need more aggressive treatment. CRP remains a low-cost marker of embolic risk. A high PCT value should suggest S. aureus etiology..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
BMC Infectious Diseases - 21(2021), 1, Seite 11 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rosa Zampino [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biomarkers |
|---|
| doi: |
10.1186/s12879-020-05655-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ057831351 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ057831351 | ||
| 003 | DE-627 | ||
| 005 | 20230308220810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12879-020-05655-7 |2 doi | |
| 035 | |a (DE-627)DOAJ057831351 | ||
| 035 | |a (DE-599)DOAJa908c24d123a4962b56234249103be5b | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Rosa Zampino |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Infective endocarditis (IE) is a life-threatening disease whose prognosis is often difficult to predict based on clinical data. Biomarkers have been shown to favorably affect disease management in a number of cardiac disorders. Aims of this retrospective study were to assess the prognostic role of procalcitonin (PCT), pro-adrenomedullin (pro-ADM) and copeptin in IE and their relation with disease characteristics and the traditional biomarker C-reactive protein (CRP). Methods We studied 196 patients with definite IE. Clinical, laboratory and echocardiography parameters were analyzed, with a focus on co-morbidities. PCT, pro-ADM and copeptin were measured on stored plasma samples obtained on admission during the acute phase of the disease. Results Pro-ADM and copeptin were significantly higher in older patients and associated with prior chronic kidney disease. Pro-ADM was an independent predictor of hospital mortality (OR 3.29 [95%C.I. 1.04–11.5]; p = 0.042) whilst copeptin independently predicted 1-year mortality (OR 2.55 [95%C.I. 1.18–5.54]; p = 0.017). A high PCT value was strictly tied with S. aureus etiology (p = 0.001). CRP was the only biomarker associated with embolic events (p = 0.003). Conclusions Different biomarkers correlate with distinct IE outcomes. Pro-ADM and copeptin may signal a worse prognosis of IE on admission to the hospital and could be used to identify patients who need more aggressive treatment. CRP remains a low-cost marker of embolic risk. A high PCT value should suggest S. aureus etiology. | ||
| 650 | 4 | |a Heart valve disease | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Heart failure | |
| 650 | 4 | |a Organ dysfunction | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Domenico Iossa |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Paola Ursi |e verfasserin |4 aut | |
| 700 | 0 | |a Lorenzo Bertolino |e verfasserin |4 aut | |
| 700 | 0 | |a Roberto Andini |e verfasserin |4 aut | |
| 700 | 0 | |a Rosa Molaro |e verfasserin |4 aut | |
| 700 | 0 | |a Oriana Fabrazzo |e verfasserin |4 aut | |
| 700 | 0 | |a Silvia Leonardi |e verfasserin |4 aut | |
| 700 | 0 | |a Luigi Atripaldi |e verfasserin |4 aut | |
| 700 | 0 | |a Emanuele Durante-Mangoni |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Infectious Diseases |d BMC, 2003 |g 21(2021), 1, Seite 11 |w (DE-627)DOAJ000056693 |x 14712334 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:1 |g pages:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12879-020-05655-7 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a908c24d123a4962b56234249103be5b |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12879-020-05655-7 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2334 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 1 |h 11 | ||